A deletion/insertion polymorphism in the transcriptional control region of the serotonin transporter gene (5-HTTLPR) was reported to be associated with dimensional measures of neuroticism, 1 although subsequent replication attempts have failed.
Quantitative genetic studies show approximately 40% heritability for neuroticism (emotional instability), a major dimension of human personality. 7, 8 People who report higher levels of neuroticism are prone to experience depression and anxiety 9 and the same genes associated with neuroticism are thought to confer risk for major depression and some anxiety disorders. 10, 11 Dysregulation of the central serotonergic system is implicated in the etiology of these disorders 12, 13 and the efficacy of the selective serotonin reuptake inhibitors in treating depression and anxiety suggests that the serotonin transporter gene may be involved. The serotonin transporter affects serotonergic neurotransmission by reuptake of synaptic serotonin; 14 in turn, rates of serotonergic reuptake may vary among individuals, and such variability (as modeled in platelets) is partly under genetic control. 15 The serotonin transporter gene is located on chromosome 17q11.2 16, 17 and a functional deletion/insertion polymorphism has been identified in the transcriptional control region (5-HTTLPR). 18 The short form of this variant, designated 's', is associated with lower basal and induced transcriptional efficiency of the serotonin transporter gene promoter, resulting in lower serotonin uptake activity, when compared to the long form, designated 'l'. 1, 18, 19 Recently, Lesch et al 1 reported that the 5-HTTLPR polymorphism accounted for 3-4% of population variability in neuroticism. In two predominantly male samples, individuals with either the s/s or l/s genotype (S) scored higher for Neuroticism on the NEO Personality Inventory (NEO-PI-R) 6 than persons with the l/l genotype (L). Further analyses on the six subscales of the overall NEO-Neuroticism factor revealed significantly higher Anxiety, Angry Hostility, Depression, and Impulsiveness scores in the S group, but no differences in Self-consciousness or Vulnerability. When samples were combined (n = 505 adults), NEO-PI-R Agreeableness scores were lower in the S group, indicating a more antagonistic personality associated with the S genotypes. Finally, estimated scores on the Harm Avoidance Scale of the Tridimensional Personality Questionnaire (TPQ), which is conceptually related to anxiety, 20 were higher in the S group. These results suggest that the s allele, which is related to lower serotonin reuptake, is associated with the dimensional traits of anxiety and depression.
Subsequent attempts to replicate the association between the 5-HTTLPR polymorphism and neuroticism have failed. Ebstein reported no association between the serotonin transporter polymorphism and peer ratings of NEO Neuroticism in a sample selected for extreme scores, but did not assess neuroticism in the individuals who were genotyped.
The current study was conducted in a further attempt to replicate the analyses of Lesch et al. The three genotypes for the serotonin transporter polymorphism were distributed according to the Hardy-Wein-berg equilibrium for white participants, with 34%, 50% and 16% in the l/l, l/s and s/s groups, respectively. Sixty-five percent of the black participants were homozygous for the l allele and the remaining black participants were all l/s heterozygotes; no black participants were homozygous for the s/s genotype. Because Gelernter et al 21 reported that the serotonin transporter protein allele frequencies differed by ethnicity, we compared the allele frequencies of the black and white subjects. The frequency of the long allele in white subjects was 59%, compared with 82% in the black subjects. These frequencies were similar to those reported by Gelernter et al 21 and differed significantly ( 2 1 = 7.0, P Ͻ 0.01). In addition, three black women showed the extra long variant of the polymorphism described by Gelernter et al 21 and were not included in the analyses. Because the number of African-Americans (n = 31) in our sample was undoubtedly too low to detect reliable group differences, we restricted our analyses to white subjects only (n = 225). Nevertheless, comparable analyses conducted on this small sample of African-American subjects revealed no significant effect of genotype on the measures of personality.
As shown in Table 1 , the L and S groups had identical Neuroticism scores. Analyses indicated that the two groups did not differ with respect to any of the five personality factors or the six Neuroticism facets in white subjects (P's Ͼ 0.26), nor did estimated TPQ scores differ significantly between groups (P's Ͼ 0.73). Further, in contrast to the results reported by Lesch et al, Agreeableness scores were higher in the S group, when compared to the L group, although the difference was not statistically significant. When sex was included as a factor in the analyses of the personality measures, only one significant Genotype × Sex interaction emerged (F (1,221) = 4.62, P = 0.03); men in the L group reported higher Anxiety than did men in the S group (X 's = 54.1 vs 48.5), whereas genotype was unrelated to Anxiety in women (X 's = 50.0 vs 50.4).
It should be noted that the findings reported by Lesch et al 1 were based on two samples that were predominantly male. Subsequent studies, including our own, have sampled a greater proportion of women, and have not replicated the original finding. Indeed in our sample, which was comprised of 50% women, the only statistically significant finding indicated that men with the L genotype were more likely to endorse anxiety- 1 In addition, the sample examined by Lesch et al 1 was ethnically diverse; approximately 80% of the sample was Caucasian. Ethnic differences in the phenotypic traits under investigation and the allele frequencies, as reported by Nakamura et al, 4 Gelernter et al, 21 and reflected in our sample, may explain, in part the lack of an association between the 5-HTTLPR polymorphism and neuroticism. Our analyses, which were restricted to Caucasian individuals, suggest that the association between the serotonin transporter polymorphism and neuroticism is not present in whites.
Neuroticism shares common genetic origins with affective and anxiety disorders, with each of many genes thought to contribute small amounts of variance. The efficacy of the selective serotonin reuptake inhibitors in treating depression and anxiety suggests that the serotonin transporter gene is involved. Several association studies with the 5-HTTLPR polymorphism have shown a higher frequency of the 's' allele in individuals with affective disorder. 19, [22] [23] [24] In contrast, one study has reported a higher frequency of the 'l' allele in people with obsessive compulsive disorder. 25 Other studies have found no association between an anxiety disorder diagnosis and the 5-HTTLPR polymorphism. [26] [27] [28] These inconsistencies, together with the lack of an association between the 5-HTTLPR polymorphism and neuroticism in the current sample and others, suggest that the serotonin transporter gene does not contribute to the shared genetic risk for neuroticism and affective and anxiety disorder diagnoses. It should be noted, however, that all but one of the replication attempts 3 are constrained by low statistical power. The smaller of the two samples examined by Lesch included 221 subjects and yielded the largest effect size of the three samples. Assuming an effect size of 0.33 (X 1 − X 2 /s.d.), the power to appropriately reject the null hypothesis when it is invalid in our sample of 225 individuals was 0.63. This effect size suggests that sample sizes of 350 or more are necessary to test the hypothesis that the 5-HTTLPR polymorphism is associated with neuroticism with conventional levels of statistical power (ie, 80%).
To conclude, in view of our findings, combined with the reports of Ball et al, 5 Ebstein et al, 2 Jorm et al 3 and
Nakamura et al, 4 the reproducibility of the Lesch association 1 between the 5-HTTLPR polymorphism and Neuroticism remains questionable. These contradictory findings suggest the need to attempt replication in a large, normative sample that is stratified for ethnicity and sex.
Methods

Subjects
Subjects were participants in a study designed to examine the association of serum cholesterol with mood and neurobehavioral functioning. Community volunteers were recruited from southwestern Pennsylvania through advertisements and distribution of study brochures. Approximately half of the sample had LDLcholesterol levels Ն160 mg dl −1 and exclusion criteria included diagnoses of psychotic disorders, cancer, stroke, insulin-dependent diabetes, chronic kidney or liver disease, use of psychotropic, glucocorticoid, or hypolipidemic medication; and in women, pregnancy or lactation. All participants completed a battery of self-report questionnaires, including the NEO-PI-R. 6 Tscores for the five NEO-PI-R factors of Neuroticism, Extraversion, Openness, Agreeableness, and Conscientiousness were computed and the three TPQ dimensions of Harm Avoidance, Novelty Seeking, and Reward Dependence were estimated from the NEO factor scores as described by Costa and McCrae. 29 The study protocol was approved by the IRB committee at the University of Pittsburgh and informed consent was obtained.
Near the completion of the project, participants were contacted to provide tissue for DNA extraction. Of the 343 individuals contacted, 81% provided a sample; the remainder could not be located or refused participation in the study. Genotyping was performed for the 5-HTTLPR for 271 individuals. Two samples did not amplify and were not genotyped. The sample was predominantly Caucasian (84%) and 14% of the sample was African-American. Half of the sample was female.
Genotyping
Genomic DNA was isolated from buccal brushes using the Puregene kit (Gentra Systems, Minneapolis, MN, USA). The serotonin transporter gene (SLC6A4) promoter polymorphism was typed by DNA amplification (PCR) using flanking primers 5ЈCTT GTT GGG GAT TCT CCC GCC TGG CGT T-3Ј (forward) and 5Ј-TCG AGG CTG AGC GTC TAG AGG GAC TGA GCT GG-3Ј (reverse). PCR was performed in a 30-l reaction containing 100-200 ng DNA, 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 1.5 mM MgCl 2 , 0.1 g each primer, 0.083 mM 7-deaza-2-deoxyGTP/dGTP, 0.17 mM dATP, dCTP, dTTP, and 1 U Taq DNA polymerase (Gibco BRL, Gaithersburg, MD, USA). DNA was denatured at 95°C for 5 min and subjected to 35 cycles of 45 s denaturation at 95°C, 1 min annealing at 66°C and 1 min extension at 72°C. Amplification products were resolved by electrophoresis on 2% agarose gels and visualized with ethidium bromide staining. Alleles were designated s (484 bp) and l (528 bp) according to Lesch et al. 1 
Statistical analysis
To replicate the analyses of Lesch et al, 1 a series of oneway analyses of variance (ANOVA), comparing the l/l homozygotes (L) with subjects having any s allele (l/s + s/s), was conducted on the five NEO-PI-R factors (T-scores), the six Neuroticism subscales and the three estimated TPQ dimensions. We tested the hypotheses that individuals in the S group would report higher Neuroticism (and have higher scores on the accompanying subscales), lower Agreeableness, and higher Harm Avoidance than individuals in the L group. Because 50% of our sample was female, we also repeated the analyses including sex as a between subjects factor; however, no specific hypotheses were posited regarding potential sex differences in 5-HTTLPR influences on the personality measures.
